Atlanta, Georgia's Emory University School of Medicine has long attracted the highest caliber of professionals. Daniel L. Miller, M.D, the facility's chief of General Thoracic Surgery and surgical director of the Thoracic Oncology Program at the hospital's Winship Cancer Institute, is considered to be one of the world's leading authorities on lung cancer and mesothelioma.
Pleural and Lung Cancer
Excellence in Research
Minimally Invasive Surgery
His goal is a minimally invasive treatment program for thoracic malignancies, including lung cancer and mesothelioma. He’s succeeded in using CT scans to detect and analyze small non-small lung cancers, and treating malignant pleural effusions with hyperthermic pleural lavage. He’s applying proteomics to diagnose malignant mesothelioma based on the pleural fluid of patients exposed to high asbestos levels.
Surgical Director, Thoracic Oncology Program
Throughout his career, Miller has completed surgeries such as laparoscopic anti-reflux surgery, lobectomy and lung transplantation.
His main focus is utilizing trimodal therapy for malignant pleural mesothelioma, in which induction chemotherapy is given, followed by extrapleural pneumonectomy (removing affected lung tissue, along with affected diaphragm, chest and/or heart lining portions) and then adjuvant radiation.
Miller, who has received numerous honors and awards for his work, and his Emory colleagues have their own recommendations for treating malignant mesothelioma.
“Our preference is single-port thoracoscopy at the time of diagnosis,” Miller said. “We also recommend delaying any chemical pleurodesis until the postchemotherapy mediastinoscopy assessment.”
I think for all of us who deal with mesothelioma, the number one objective is to have the patient to complete trimodality therapy as planned, which offers the best chance for cure.”
– Daniel Miller M.D.
Miller’s publications primarily address surgical topics for lung cancer, mesothelioma and other related malignancies. In 2011, his article “Impact of Laterality on Early and Late Survival after Pneumonectomy” was published in the Annals of Thoracic Surgery.
Disclaimer: Dr. Daniel Miller has no professional affiliation with Asbestos.com.
Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.
View our resources for patients and familiesGet Help Today